Core·it Dual
Spident Co., Ltd. · Decision date Sep 21, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Core·it Dual, a 510(k) submitted by Spident Co., Ltd. of Incheon, KR, under 510(k) number K262982. The record lists the device classification name as Material, Tooth Shade, Resin, regulation number 872.3690, product code EBF, and the Dental medical specialty and review panel. The application was received 08/27/2026 and decided 09/21/2026.
SESE denotes clearance to market, not premarket approval. The record shows no third-party review, no combination product designation, and no authorized predetermined change control plan. The public listing does not include a summary statement, so the specific formulation, shade range, indications for use, and any comparison to a predicate device remain unknown from this source.
The page was last updated 10/26/2026. No clinical or performance data are presented here, and none should be inferred from the decision alone.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Sep 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262982
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Spident Co., Ltd.
- Product code
- EBF
- Decision code
- SESE
- Decision date
- Sep 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Material, Tooth Shade, Resin.
- Applicant
- Spident Co., Ltd.
- Product code
- EBF
- FDA device class
- 2
FDA decision timeline
K262982 received
Application receipt date recorded by FDA.
K262982 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code EBF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Cerasmart ForteK262202 | GC America, Inc. | 510(k) clearance | Sep 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Spident Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Incheon
Sources and methodology
- Original FDA record: K262982
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records